Advancing Efforts in Disease Interception - a podcast by Scientific American
from 2020-02-27T11:45
::
::
Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Further episodes of Science Talk
Further podcasts by Scientific American
Website of Scientific American